Topmunnity Therapeutics Limited

Topmunnity Therapeutics provides innovative and advanced biologic solutions that address critical unmet medical needs. Founded in 2019, Topmunnity Therapeutics integrates a team of experts in biotechnology, pharmaceutical development and artificial intelligence to revolutionize disease treatment. Topmunnity is advancing two pipeline products: an antibody-drug conjugate (ADC), TT-01 ADC and a chimeric antigen receptor T-Cell therapy CAR-108.Through AI-drivened antibody modeling and cheminformatics-based molecular dynamics, we accelerate the development of innovative functional antibodies, offering novel therapeutic possibilities for cancer and other complex diseases, reshaping the future of medicine. At Topmunnity, we firmly believe that people are the cornerstone of medical advancements in healthcare. We value every team member who strives for personal growth, embraces challenges, and demonstrates resilience in the face of adversity, all with the mission of enhancing human health and well-being. Driven by a rigorous scientific approach and a strong spirit of accountability, we pursue excellence and foster innovation. Through an open and collaborative environment ,coupled with ample development resources, we empower each team member to realize their full potential, and to achieve the long-term vision of improving human health.